By designing and delivering a truncated, catalytically active form of DAPK1 (∆DAPK1‐mRNA), we successfully reactivated its pro‐apoptotic functions in HGSOC cells, including paclitaxel‐resistant models and primary patient‐derived tumor cells. Here, DAPK1 is linked to neoplasm.